1. Home
  2. VC vs LQDA Comparison

VC vs LQDA Comparison

Compare VC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$87.55

Market Cap

2.6B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$36.62

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
LQDA
Founded
2000
2004
Country
United States
United States
Employees
10000
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
VC
LQDA
Price
$87.55
$36.62
Analyst Decision
Buy
Strong Buy
Analyst Count
14
11
Target Price
$120.83
$41.00
AVG Volume (30 Days)
476.7K
1.4M
Earning Date
04-23-2026
03-05-2026
Dividend Yield
1.71%
N/A
EPS Growth
N/A
51.81
EPS
7.28
N/A
Revenue
$3,768,000,000.00
$158,320,000.00
Revenue This Year
$2.31
$265.61
Revenue Next Year
$5.24
$62.82
P/E Ratio
$12.04
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$65.17
$11.26
52 Week High
$128.32
$46.67

Technical Indicators

Market Signals
Indicator
VC
LQDA
Relative Strength Index (RSI) 40.49 52.48
Support Level $82.35 $31.75
Resistance Level $105.72 $39.19
Average True Range (ATR) 2.57 1.83
MACD 0.01 0.15
Stochastic Oscillator 42.09 51.61

Price Performance

Historical Comparison
VC
LQDA

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: